SCHEMBL13348407

SCHEMBL13348407

Cc1ccccc1C(=O)N1CCc2cccc(COc3ccc(CCC=O)c(F)c3)c21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 4/20 0.38
FFAR4 Q5NUL3 1/20 0.38
PTGER4 P35408 1/20 0.38
PTGER2 P43116 1/20 0.38
HDAC6 Q9UBN7 5/20 0.38
CD274 Q9NZQ7 4/20 0.38
PDCD1 Q15116 3/20 0.38
HDAC1 Q13547 4/20 0.36
ALDH1A1 P00352 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTT P42858 1/20 0.36
PARP10 Q53GL7 2/20 0.36
PARP14 Q460N5 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13348283 0.90 ALDH1A1 (0.46) PTGER4PTGER2ALDH1A1PARP10PARP14
SCHEMBL13312474 0.89 FFAR1 (0.51) FFAR1FFAR4CD274
SCHEMBL13348170 0.85 PTGER4 (0.39) FFAR1FFAR4PTGER4PTGER2HDAC6
SCHEMBL13348240 0.84 PTGER2 (0.49) PTGER4PTGER2ALDH1A1HPGDMEN1
SCHEMBL13348138 0.83 HPD (0.41) PTGER4PTGER2HDAC6CD274PDCD1
SCHEMBL13348045 0.81 DRD2 (0.39) FFAR1PTGER4PTGER2CD274ALDH1A1
SCHEMBL13348046 0.80 PTGER2 (0.37) FFAR1FFAR4PTGER4PTGER2HDAC6
SCHEMBL13312467 0.79 FFAR1 (0.43) FFAR1FFAR4PTGER4PTGER2CD274
SCHEMBL13312466 0.79 ALDH1A1 (0.46) FFAR1FFAR4PTGER4PTGER2ALDH1A1
SCHEMBL13348179 0.79 PTGER4 (0.43) FFAR1FFAR4PTGER4PTGER2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152165-A1 CARBOXYLIC ACID DERIVATIVES ASTELLAS PHARMA INC. (JP) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152165-A1 CARBOXYLIC ACID DERIVATIVES GPR119, GPR65, HCAR1 FFAR1 14/4885FFAR4 15/4885PTGER4 1432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.